Human papillomavirus types 16 and 18 vaccine (recombinant, AS04 adjuvanted, adsorbed) [Cervarix]: profile report.
Keam
Susan J
SJ
Wolters Kluwer Health Adis, Auckland, New Zealand. demail@adis.co.nz
Harper
Diane M
DM
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D005260:Female; D052162:Human papillomavirus 16 / Q000276:immunology*; D052161:Human papillomavirus 18 / Q000276:immunology*; D006801:Humans; D053918:Papillomavirus Vaccines / Q000009:adverse effects / Q000276:immunology*; D014611:Vaccination; D014614:Vaccines, Synthetic / Q000276:immunology*
D053918:Papillomavirus Vaccines; D014614:Vaccines, Synthetic; C510352:human papillomavirus vaccine, L1 type 16, 18